Full Text View
Tabular View
No Study Results Posted
Related Studies
Effects of Tolterodine, a Non-Specific Muscarinic Antagonist, on Gastrointestinal Transit in Healthy Subjects
This study has been completed.
Study NCT00332137   Information provided by Mayo Clinic
First Received: May 30, 2006   Last Updated: August 10, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Health
Interventions listed in this trial
Tolterodine
Additional drug interventions recognized in this trial
Muscarinic Antagonists
More general drug interventions related to this trial
Cholinergic Agents
Cholinergic Antagonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Mayo Clinic
Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services